Works matching DE "RITONAVIR"

Results: 1089
    1
    2
    3
    4

    Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria.

    Published in:
    European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1341, doi. 10.1007/s00228-021-03116-x
    By:
    • Usman, Sikiru Olatunji;
    • Oreagba, Ibrahim Adekunle;
    • Kadri, Michael Rotimi;
    • Adewumi, Ololade Oluwatosin;
    • Akinyede, Akinwumi;
    • Agbaje, Esther Oluwatoyin;
    • Abideen, Ganiyu;
    • Busari, AbdulWasiu Adeniyi;
    • Hassan, Olayinka Olaiwola;
    • Akinleye, Moshood Olusola;
    • Akanmu, Alani Sulaimon
    Publication type:
    Article
    5
    6

    Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials

    Published in:
    European Journal of Clinical Pharmacology, 2019, v. 75, n. 2, p. 207, doi. 10.1007/s00228-018-2566-6
    By:
    • Shuster, Diana L.;
    • Menon, Rajeev M.;
    • Ding, Bifeng;
    • Khatri, Amit;
    • Li, Hong;
    • Cohen, Eric;
    • Jewett, Melissa;
    • Cohen, Daniel E.;
    • Zha, Jiuhong
    Publication type:
    Article
    7
    8
    9
    10

    Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.

    Published in:
    European Journal of Clinical Pharmacology, 2014, v. 70, n. 10, p. 1173, doi. 10.1007/s00228-014-1732-8
    By:
    • Song, Ivy;
    • Borland, Julie;
    • Chen, Shuguang;
    • Guta, Phyllis;
    • Lou, Yu;
    • Wilfret, David;
    • Wajima, Toshihiro;
    • Savina, Paul;
    • Peppercorn, Amanda;
    • Castellino, Stephen;
    • Wagner, David;
    • Hosking, Louise;
    • Mosteller, Michael;
    • Rubio, Justin;
    • Piscitelli, Stephen
    Publication type:
    Article
    11
    12
    13
    14

    The Efficacy and Safety of Adding Chlorpromazine to Atazanavir/Ritonavir Regimen in the Treatment of Moderate COVID-19 Patients, a Randomized Double-blind Clinical Trial.

    Published in:
    Pharmaceutical & Biomedical Research, 2023, v. 9, n. 3, p. 211, doi. 10.32598/PBR.9.3.1084.1
    By:
    • Kame/aninejad, Sima;
    • Namvar, Hamid Reza;
    • Sohrabi, Masoumeh;
    • Darvishnia, David;
    • Ahangar, Nematollah;
    • A]ikhani, Ahmad;
    • Abbaspour, Hamideh;
    • Valadan, Reza;
    • Akbari, Zahra;
    • Akbari, Jafar;
    • Ghasemian, Roya;
    • Salehifar, Ebrahim
    Publication type:
    Article
    15

    Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series.

    Published in:
    Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00361-x
    By:
    • Naganawa, Hanako;
    • Katada, Yoshiki;
    • Nakagawa, Shunsaku;
    • Umemura, Keisuke;
    • Ishimura, Hiroki;
    • Kajiwara, Moto;
    • Endo, Hiroki;
    • Sugimoto, Mitsuhiro;
    • Katsube, Yurie;
    • Kotani, Kinuka;
    • Ohta, Saki;
    • Hira, Daiki;
    • Tsuda, Masahiro;
    • Kita, Yuki;
    • Kobayashi, Takashi;
    • Terada, Tomohiro
    Publication type:
    Article
    16

    A case report of a prolonged decrease in tacrolimus clearance due to co-administration of nirmatrelvir/ritonavir in a lung transplant recipient receiving itraconazole prophylaxis.

    Published in:
    Journal of Pharmaceutical Health Care & Sciences, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40780-023-00280-3
    By:
    • Tsuzawa, Ayumi;
    • Katada, Yoshiki;
    • Umemura, Keisuke;
    • Sugimoto, Mitsuhiro;
    • Nishikawa, Asami;
    • Sato, Yu-ki;
    • Yoshida, Yuko;
    • Kitada, Noriaki;
    • Yonezawa, Atsushi;
    • Nakajima, Daisuke;
    • Date, Hiroshi;
    • Terada, Tomohiro
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.

    Published in:
    Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.602841
    By:
    • Ramírez, Elena;
    • Urroz, Mikel;
    • Rodríguez, Amelia;
    • González-Muñoz, Miguel;
    • Martín-Vega, Alberto;
    • Villán, Yuri;
    • Seco, Enrique;
    • Monserrat, Jaime;
    • Frías, Jesús;
    • Carcas, Antonio J.;
    • Borobia, Alberto M.
    Publication type:
    Article
    25
    26
    27

    No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study

    Published in:
    Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.01071
    By:
    • Huang, Yin-Qiu;
    • Tang, Sheng-Quan;
    • Xu, Xiao-Lei;
    • Zeng, Yan-Ming;
    • He, Xiao-Qing;
    • Li, Yao;
    • Harypursat, Vijay;
    • Lu, Yan-Qiu;
    • Wan, Yan;
    • Zhang, Lu;
    • Sun, Qiang-Zhong;
    • Sun, Nan-Nan;
    • Wang, Gui-Xue;
    • Yang, Zhong-Ping;
    • Chen, Yao-Kai
    Publication type:
    Article
    28
    29

    Six-Year Immunologic Recovery and Virological Suppression of HIV Patients on LPV/r-Based Second-Line Antiretroviral Treatment: A Multi-Center Real-World Cohort Study in China.

    Published in:
    Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01455
    By:
    • Huang, Xiaojie;
    • Xu, Liumei;
    • Sun, Lijun;
    • Gao, Guiju;
    • Cai, Weiping;
    • Liu, Yanfen;
    • Ding, Haibo;
    • Wei, Hongxia;
    • Ma, Ping;
    • Wang, Min;
    • Liu, Shuiqing;
    • Chen, Yaokai;
    • Chen, Xiaohong;
    • Zhao, Qingxia;
    • Yu, Jianhua;
    • Song, Yuxia;
    • Chen, Hui;
    • Wu, Hao;
    • Qin, Shanfang;
    • Li, Linghua
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.

    Published in:
    PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192627
    By:
    • Taramasso, Lucia;
    • Di Biagio, Antonio;
    • Bovis, Francesca;
    • Nicolini, Laura Ambra;
    • Antinori, Andrea;
    • Milazzo, Laura;
    • Sollima, Salvatore;
    • Gubertini, Guido;
    • Niero, Fosca;
    • Saracino, Annalisa;
    • Bruno, Raffaele;
    • Borghi, Vanni;
    • Montagnani, Francesca;
    • Cattelan, Annamaria;
    • Hasson, Hamid;
    • Taliani, Gloria;
    • D’Arminio Monforte, Antonella;
    • Mastroianni, Claudio;
    • Di Perri, Giovanni;
    • Bigoni, Sara
    Publication type:
    Article
    45
    46
    47
    48
    49
    50